Applications, challenges, and prospects of induced pluripotent stem cells for vascular disease

Area of Science:

• Regenerative Medicine
• Vascular Biology
• Stem Cell Research

Background:

• Vascular diseases pose a major global health challenge, causing significant mortality and disability.
• Human induced pluripotent stem cells (hiPSCs), developed in 2007, present novel avenues for understanding disease mechanisms and advancing regenerative medicine.
• Current research explores hiPSC-derived vascular cells for disease modeling and therapeutic applications.

Purpose of the Study:

• To review vascular physiology and diseases.
• To discuss methods for generating vascular cells from hiPSCs.
• To explore clinical applications and challenges of hiPSC-based vascular technologies.

Main Methods:

• Review of current literature on vascular cell generation from hiPSCs.
• Analysis of opportunities and challenges in vascular organoids, tissue-engineered blood vessels, and vessels-on-a-chip.
• Exploration of hiPSC applications in inherited vascular diseases.

Main Results:

• hiPSCs provide a platform for studying vascular pathophysiology and disease modeling.
• Vascular organoids, engineered vessels, and vessels-on-a-chip show promise but face challenges for clinical use.
• hiPSCs are being investigated for treating inherited vascular conditions.

Conclusions:

• hiPSC technology is crucial for advancing vascular disease research and regenerative medicine.
• Developing vascularized organoids that mimic physiological conditions (shear stress, cyclic stretching) is key for future progress.
• Enhanced vascular organoid models will improve disease modeling and accelerate drug discovery for vascular disorders.